Sponsor

Fastox Pharma S.A.

Rue Du Petit-Chene 12, 1003

About the sponsor

Fastox Pharma S.A. is involved in clinical research focused on glabellar lines, with interest in treatments aimed at reducing the appearance of frown lines between the eyebrows.

Glabellar line treatment
Facial wrinkle correction
Aesthetic dermatology

The sponsor’s research activity is centered on injectable therapies for visible facial line management in adults with severe glabellar lines.

About Specializations

Fastox Pharma S.A. runs clinical trials in conditions such as Skin wrinkling, among others.

Skin wrinkling

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Quick filters

1 clinical trial

Skin wrinkling

Not recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of Dantrolene Sodium and Botulinum Toxin Type A for Treating Severe Glabellar Lines in Adults

Registered drugNo placebo

Germany

Participants:18–64 years · Healthy volunteers
Substances:Dantrolene Sodium
Sponsor:Fastox Pharma S.A.

Contact Research Centre

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →